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Acute neutrophil (PMN) recruitment to postischemic car-
diac or pulmonary tissue has deleterious effects in the early
reperfusion period, but the mechanisms and effects of neu-
trophil influx in the pathogenesis of evolving stroke remain
controversial. To investigate whether PMNs contribute to
adverse neurologic sequelae and mortality after stroke, and
to study the potential role of the leukocyte adhesion mole-
cule intercellular adhesion molecule-1 (ICAM-1) in the
pathogenesis of stroke, we used a murine model of transient
focal cerebral ischemia consisting of intraluminal middle
cerebral artery occlusion for 45 min followed by 22 h of re-




In-labeled PMNs in postischemic cerebral tissue, was in-
creased 2.5-fold in the ipsilateral (infarcted) hemisphere







 0.01). Mice immunodepleted of neutrophils before sur-







 0.001), based on triphenyltetrazolium chloride staining
of serial cerebral sections, improved ipsilateral cortical cere-
bral blood flow (measured by laser Doppler), and reduced
neurological deficit compared with controls. In wild-type
mice subjected to 45 min of ischemia followed by 22 h of
reperfusion, ICAM-1 mRNA was increased in the ipsilateral
hemisphere, with immunohistochemistry localizing in-
creased ICAM-1 expression on cerebral microvascular en-
dothelium. The role of ICAM-1 expression in stroke was in-
























 mice demonstrated a 3.7-fold reduction






















 controls. Cerebral blood flow to the infarcted























 0.01), suggesting an
important role for ICAM-1 in the genesis of postischemic
cerebral no-reflow. Because PMN-depleted and ICAM-1–
deficient mice are relatively resistant to cerebral ischemia-
reperfusion injury, these studies suggest an important role
for ICAM-1–mediated PMN adhesion in the pathophysiol-





















Neutrophils (PMNs) are critically involved in the earliest
stages of inflammation after tissue ischemia, initiating scaven-
ger functions which are later subsumed by macrophages. How-
ever, there is a darker side to neutrophil influx, especially in
postischemic tissues (1–7), where activated PMNs may aug-
ment damage to vascular and parenchymal cellular elements.
Experimental evidence points to a pivotal role for endothelial
cells in establishing postischemic PMN recruitment, in that hy-
poxic/ischemic endothelial cells synthesize the proinflamma-
tory cytokine IL-1 (8) as well as the potent neutrophil chemo-
attractant and activator IL-8 (9). Firm adhesion of PMNs to
activated endothelium in a postischemic vascular milieu is pro-
moted by translocation of P-selectin to the cell surface (10) as





 and intercellular adhesion molecule-1 (ICAM-1) (11).
While strategies to block each of these mechanisms of neu-
trophil recruitment are protective in various models of is-
chemia and reperfusion injury, their effectiveness in cerebral
ischemia/reperfusion injury remains controversial. There is
considerable evidence that in the brain, as in other tissues, an
early PMN influx follows an ischemic episode (12–17). Immu-
nohistochemical studies have described increased expression
of the PMN adhesion molecules P-selectin and ICAM-1 in the
postischemic cerebral vasculature (12, 18–20). The pathogenic
relevance of adhesion molecule expression in the brain re-
mains controversial, however; data from a trial of a mono-
clonal anti–ICAM-1 antibody in stroke in humans are not yet
available (Rothlein, R., personal communication). In animal
models, there is conflicting experimental evidence regarding
the effectiveness of anti–adhesion molecule strategies in the
treatment of experimental stroke (21–23). To determine
whether ICAM-1 participates in the pathogenesis of postis-
chemic cerebral injury, the experiments reported here were
undertaken in a murine model of focal cerebral ischemia and
reperfusion so that the role of a single, critical mediator of
PMN adhesion (ICAM-1) could be determined. These studies
demonstrate that enhanced ICAM-1 expression and neutro-
phil influx follow an episode of focal cerebral ischemia. Fur-
thermore, these studies show that both neutrophil-deficient
and transgenic ICAM-1 null mice are relatively resistant to ce-
rebral infarction after ischemia and reperfusion, providing
strong evidence for an exacerbating role of ICAM-1 in the
pathophysiology of stroke.
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Experiments were performed with transgenic ICAM-1–defi-
cient mice created as reported previously (24) by gene targeting in J1
embryonic stem cells, injected into C57BL/6 blastocysts to obtain
germline transmission and backcrossed to obtain homozygous null

















) cousin mice from the fifth generation of
backcrossings with C57BL/6 mice. Animals were 7–9 wk of age and
weighed between 25 and 36 grams at the time of experiments. For
certain experiments, neutrophil depletion of C57BL/6 mice was ac-
complished by administering polyclonal rabbit anti–mouse neutrophil
antibody (25) (Accurate Chemical & Scientific Corp., Westbury, NY)
preadsorbed to red blood cells as a daily intraperitoneal injection (0.3
ml of 1:12 solution) for 3 d. Experiments in these mice were per-
formed on the fourth day after confirming agranulocytosis by Wright-
Giemsa–stained peripheral blood smears.
 
Transient middle cerebral artery occlusion (26).
 
Mice were anes-
thetized with an intraperitoneal injection of 0.3 ml of ketamine (10
mg/ml) and xylazine (0.5 mg/ml). Animals were positioned supine on
a rectal temperature–controlled operating surface (Yellow Springs





C intraoperatively and for 90 min postopera-
tively. Middle cerebral artery occlusion was performed as follows: A
midline neck incision was created to expose the right carotid sheath




 zoom; Carl Zeiss, Inc.,
Thornwood, NY). The common carotid artery was freed from its
sheath and isolated with a 4-0 silk, and the occipital and pterygopa-
latine arteries were each isolated and divided. Distal control of the in-
ternal carotid artery was obtained, and the external carotid was cau-
terized and divided just proximal to its bifurcation into the lingual
and maxillary divisions. Transient carotid occlusion was accom-
plished by advancing a 13-mm heat-blunted 5-0 nylon suture via the
external carotid stump to the origin of the middle cerebral artery. Af-
ter placement of the occluding suture, the external carotid artery
stump was cauterized to prevent bleeding through the arteriotomy,
and arterial flow was reestablished. In all cases, the duration of ca-




 2 min. After 45 min, the occluding suture was
withdrawn to establish reperfusion. These procedures have been de-
scribed previously in detail (26).
 
Measurement of cerebral cortical blood flow.
 
Transcranial mea-
surements of cerebral blood flow were made using laser Doppler flow
measurements (Perimed, Inc., Piscataway, NJ) after reflection of the
skin overlying the calvarium, as described previously (27) (transcra-
nial readings were consistently the same as those made after craniec-
tomy in pilot studies). Using a 0.7-mm straight laser Doppler probe
(model PF303; Perimed, Inc.) and previously published landmarks (2
mm posterior to the bregma, 6 mm to each side of midline), relative
cerebral blood flow measurements were made as indicated; immedi-
ately after anesthesia, after occlusion of the middle cerebral artery,
immediately after reperfusion, and at 24 h just before euthanasia.
Data are expressed as the ratio of the Doppler signal intensity of the
ischemic compared with the nonischemic hemisphere. Although this
method does not quantify cerebral blood flow per gram of tissue, use
of laser Doppler flow measurements at precisely defined anatomic
landmarks serves as a means of comparing cerebral blood flows in the
same animal serially over time. The surgical procedure/intraluminal
middle cerebral artery occlusion and reperfusion were considered to




50% reduction in relative cerebral blood
flow was observed immediately after placement of the intraluminal




33% increase in flow over baseline occlu-
sion was observed immediately after removal of the occluding suture.
These methods have been used in previous studies (26).
 







Citrated blood from wild-type mice was diluted 1:1 with NaCl
(0.9%) followed by gradient ultracentrifugation on Ficoll-Hypaque
(Pharmacia LKB Biotechnology, Inc., Piscataway, NJ). After hypo-





lowed by reconstitution with 1.8% NaCl), the neutrophils were sus-

















In oxine (Amersham Mediphysics, Port Washington,




C. After washing with PBS, the neutrophils




) and resuspended in PBS to a final con-













radiolabeled PMNs admixed with physiologic saline to a total volume












 cpm) was administered by penile vein injection.
After humane killing, brains were obtained as described, and neutro-





24 h after middle cerebral artery occlusion
and reperfusion, before giving anesthesia, mice were examined for
neurological deficit using a four-tiered grading system (26). A score
of 1 was given if the animal demonstrated normal spontaneous move-
ments; a score of 2 was given if the animal was noted to be turning to
the right (clockwise circles) when viewed from above (i.e., toward the
contralateral side); a score of 3 was given if the animal was observed
to spin longitudinally (clockwise when viewed from the tail); and a
score of 4 was given if the animal was crouched on all fours, unre-
sponsive to noxious stimuli. This scoring system has been described
previously in mice (26) and is based upon similar scoring systems
used in rats (28, 29) which are based upon the contralateral move-
ment of animals with stroke; after cerebral infarction, the contralat-
eral side is “weak” and so the animal tends to turn toward the weak-
ened side. Previous work in rats (28) and mice (26) demonstrates that
larger cerebral infarcts are associated with a greater degree of con-
tralateral movement, up to the point where the infarcts are so large
that the animal remains unresponsive.
 
Calculation of infarct volume.
 
After neurologic examination,
mice were given 0.3 ml of ketamine (10 mg/ml) and xylazine (0.5
mg/ml), and final cerebral blood flow measurements were obtained.
Humane killing was performed by decapitation under anesthesia, and
brains were removed and placed in a mouse brain matrix (Activa-
tional Systems, Inc., Warren, MI) for 1-mm sectioning. Sections were
immersed in 2% 2,3,5, triphenyl, 2H-tetrazolium chloride (TTC;





C, and placed in 10% formalin (26, 30–32). Infarcted brain
was visualized as an area of unstained tissue, in contrast to viable tis-
sue, which stains brick red. Infarct volumes were calculated from
planimetered serial sections and expressed as the percentage of inf-
arct in the ipsilateral hemisphere.
 
RNA extraction and Northern blot analysis.
 
24 h after focal is-
chemia and reperfusion, brains were obtained and divided into ipsi-
lateral (infarct) and contralateral (noninfarct) hemispheres. To detect
ICAM-1 transcripts, total RNA was extracted from each hemisphere
using an RNA isolation kit (Stratagene, La Jolla, CA). Equal




g/lane) were loaded onto a 1.4% agarose gel
containing 2.2 M formaldehyde for size fractionation and then trans-





by capillary pressure. A murine ICAM-1 cDNA probe (33) (1.90 kb;








-dCTP by random primer labeling (Prime-A-Gene kit; Promega,









 SSC/0.05% SDS. Blots were developed with X-Omat AR film


















Brains were removed at the indicated
times after middle cerebral artery occlusion, fixed in 10% formalin,
paraffin embedded, and sectioned for immunohistochemistry. Sec-
tions were stained with a rat anti–murine ICAM-1 antibody (1:50 dilu-
tion; Genzyme Corp., Cambridge, MA), and sites of primary anti-
body binding were visualized by an alkaline phosphatase–conjugated





Cerebral blood flow, infarct volumes, and neuro-




 test for un-
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In-neutrophil deposition was evaluated as paired
data (comparing contralateral [noninfarct] with ipsilateral [infarct]
hemisphere), to control for variations in injected counts or volume of
distribution. Survival differences between groups were tested using























Neutrophil accumulation in stroke.
 
Previous pathologic stud-
ies have shown neutrophil accumulation after cerebral infarc-
tion (15–17, 34–36). To determine whether neutrophils accu-
mulate in our murine model of focal cerebral ischemia and
reperfusion, neutrophil accumulation after transient (45 min)
ischemia and reperfusion (22 h) was quantified by measuring




In-labeled neutrophils given to wild-type
mice before the ischemic event. These experiments demon-
strated significantly greater neutrophil accumulation (2.5-fold
increase) in the ipsilateral (infarcted) compared with the con-
















 0.01; Fig. 1).
Similar results were obtained when neutrophil influx was mon-
itored by myeloperoxidase assays, though low levels of activity
were recorded in the latter assay (data not shown).
 
Effect of neutrophil depletion on stroke outcome.
 
To deter-
mine the effect of neutrophil influx on indices of stroke out-
come, mice were immunodepleted of neutrophils beginning 3 d
before surgery. When surgery was performed on the fourth
day, nearly complete agranulocytosis was evident on smears of








 18) were subjected to
45 min of cerebral ischemia and 22 h of reperfusion, and indi-
ces of stroke outcome were determined. Infarct volumes were






















The decrease in infarct volumes in neutropenic mice was par-









), and a trend toward reduced overnight mortality (22%







ICAM-1 expression in murine stroke.
 
To establish the ef-
fect of cerebral ischemia/reperfusion in our murine model,
ICAM-1 mRNA levels were evaluated after cerebral ischemia
and reperfusion in wild-type mice. Ipsilateral (infarcted) cere-
Figure 1. Neutrophil accumulation after focal cerebral ischemia and 
reperfusion in the mouse. Right middle cerebral artery occlusion was 
performed for 45 min, followed by 22 h of reperfusion in male 
C57BL/J6 mice. 1 h before middle cerebral artery occlusion, <3.3 3 
105 111In-labeled neutrophils were injected into the tail vein. Ipsilat-
eral (right hemispheric) and contralateral (left hemispheric) counts 
were obtained and normalized per gram of tissue. n 5 7, **P , 0.01.
Figure 2. Effect of preoperative 
neutrophil depletion on indices 
of stroke outcome. C57BL/J6 
male mice were subjected to 
transient middle cerebral artery 
occlusion as described above 
(Wild Type, n 5 16) and com-
pared with a similar procedure 
performed in mice immuno-
depleted of neutrophils during 
the 3 d before the day of surgery 
(PMN (2), n 5 18). (A) Infarct 
volumes were calculated based 
on TTC-stained serial cerebral 
sections and were expressed as 
the percentage of ipsilateral 
hemispheric volume. (B) Neuro-
logic deficit score was graded be-
fore anesthesia 24 h after tran-
sient middle cerebral artery 
occlusion; 4 represents the most 
severe neurologic deficit. (C) 
Cerebral blood flow was mea-
sured by laser Doppler flow 
measurements 2 mm posterior to 
the bregma, expressed as per-
centage of contralateral hemi-
spheric blood flow. (D) Mortal-
ity at 24 h after transient middle 
cerebral artery occlusion. *P , 
0.05, **P , 0.01, ***P , 0.001.
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bral hemisphere demonstrated increased ICAM-1 mRNA by
Northern blot analysis compared with RNA obtained from the
contralateral (noninfarcted) hemisphere from the same animal
(Fig. 3). To evaluate ICAM-1 antigen expression in this mu-
rine model, wild-type mice were subjected to 45 min of is-
chemia followed by 22 h of reperfusion, and the cerebral
microvasculature was examined by immunohistochemistry.
ICAM-1 antigen expression was not detectable in the cerebral
microvasculature contralateral to the infarct (Fig. 4 A), but
was markedly increased on the ipsilateral side, with prominent
ICAM-1 staining of cerebral endothelial cells (Fig. 4 B).
Role of ICAM-1 in stroke. To explore the role of ICAM-1
in stroke, transgenic mice which were homozygous ICAM-1
deficient (24) were studied in the murine model of focal cere-
bral ischemia and reperfusion. Because variations in cere-
brovascular anatomy have been reported to result in differ-
ences in susceptibility to experimental stroke in mice (37),
india ink staining was performed on the circle of Willis in ho-
mozygous null (ICAM-1 2/2) and ICAM-1 1/1 mice. These
experiments (Fig. 5) demonstrated that there were no gross
anatomic differences in the vascular pattern of the cerebral cir-
culation. To determine the role of ICAM-1 in neutrophil influx
after focal cerebral ischemia and reperfusion, neutrophil ac-
cumulation was measured in homozygous null ICAM-1
mice (ICAM-1 2/2) mice (n 5 14) and wild-type controls
(n 5 7) infused with 111In-labeled neutrophils. Relative neutro-
phil accumulation (ipsilateral counts per minute/contralateral
counts per minute) was diminished (39% reduction) in the
ICAM-1 2/2 mice compared with ICAM-1 1/1 controls
(1.7060.26 vs. 2.960.52, P , 0.05).
Experiments were then performed to investigate whether
expression of ICAM-1 has a pathophysiologic role in outcome
after stroke. ICAM-1 2/2 mice (n 5 13) were significantly
protected from the effects of focal cerebral ischemia and rep-
erfusion, based on a 3.7-fold reduction in infarct volume (P ,
0.01) compared with ICAM-1 1/1 controls (Figs. 6 and 7 A).
This reduction in infarct volume was accompanied by reduced
neurologic deficit (Fig. 7 B) and increased postreperfusion ce-
rebral cortical blood flow (Fig. 7 C). Given these results, it was
not surprising that mortality was also significantly decreased in
the ICAM-1 2/2 mice compared with ICAM-1 1/1 controls
(15 vs. 50%, P , 0.05; Fig. 7 D).
Discussion
Epidemiologic evidence in humans suggests that neutrophils
contribute to the initiation of stroke (38) as well as to cerebral
Figure 3. Expression of 
ICAM-1 transcripts 24 h 
after middle cerebral ar-
tery occlusion. RNA 
was prepared from the 
ipsilateral (infarct) and 
the contralateral (nonin-
farct) hemispheres from 
the same mouse, and an 
agarose gel was loaded 
with 20 mg of total RNA 
per lane. After overnight 
transfer to a nylon mem-
brane, the Northern blot was probed with a 32P-labeled 1.90-kb mu-
rine ICAM-1 cDNA (33) (top). A b-actin probe was used for a con-
trol (bottom).
Figure 4. Expression of ICAM-1 an-
tigen in the cerebral microvascula-
ture 24 h after middle cerebral artery 
occlusion. A coronal section of brain 
was obtained for ICAM-1 immun-
ostaining, so that the noninfarcted 
and infarcted hemispheres from the 
same brain could be compared un-
der identical staining conditions. 
Staining was performed using a rat 
anti–murine ICAM-1 antibody, with 
sites of primary antibody binding vi-
sualized by alkaline phosphatase. 
(A) Cerebral microvessel in the con-
tralateral (noninfarcted) section of a 
brain obtained 24 h after middle ce-
rebral artery occlusion. (B) Cerebral 
microvessel from the ipsilateral (in-
farcted) hemisphere from the same 
section of brain as shown in A. En-
dothelial cells from ipsilateral cere-
bral microvessels demonstrate in-
creased expression of ICAM-1 
(bright red staining). 3250.
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Figure 6. TTC-stained serial sections at 24 h from representative 
wild-type (left) or homozygous null ICAM-1 mice (right) subjected to 
transient middle cerebral artery occlusion. The pale white area in the 
middle cerebral artery territory represents infarcted brain tissue, 
whereas viable tissue stains brick red. Quantification of infarct vol-
umes by planimetry of serial cerebral sections in multiple experi-
ments is shown in Fig. 7 A.
tissue injury and poor clinical outcome (39), with a potential
role for neutrophils in postischemic hypoperfusion, neuronal
dysfunction, and scar formation (40–44). Although there is
considerable experimental evidence which suggests that neu-
trophils can exacerbate tissue damage after stroke (13, 45–48),
certain pieces of experimental data have stoked controversy by
failing to find an association between agents which block neu-
trophil accumulation and indices of stroke outcome. In a rat
model of stroke, antibody-mediated depletion of neutrophils
before stroke significantly decreased brain water content and
infarct size (13). However, cyclophosphamide-induced leuko-
cytopenia in a gerbil model (49) or antineutrophil antibody ad-
ministration to dogs (50) showed no beneficial effects in global
models of cerebral ischemia. Experimental therapy targeted at
interfering with neutrophil–endothelial interactions has also
produced mixed results. In a feline model of transient focal ce-
rebral ischemia, treatment with antibody to CD18 (the com-
mon subunit of b2 integrins, which bind to intercellular adhe-
sion molecule-1 [reference 51]) did not alter recovery of
cerebral blood flow, return of evoked potentials, or infarct vol-
ume (23). However, other experiments have found that mi-
crovascular patency after transient focal ischemia in primates
is improved by antibodies to CD18 (14). In a similar rat model,
anti-CD11b/CD18 antibody has also been shown to reduce
both neutrophil accumulation and ischemia-related neuronal
damage (52).
The experiments reported here show that, in a murine
model of focal cerebral ischemia and reperfusion, neutrophils
accumulate in postischemic cerebral tissue, a finding corrobo-
rated in other models which similarly demonstrate increased
granulocyte accumulation in areas of low cerebral blood flow
early during the postischemic period (15, 16, 36, 45). Not only
do neutrophils accumulate during the postischemic period in
mice, but their presence exacerbates indices of stroke out-
come. When animals were made neutropenic before the is-
Figure 5. Cerebrovascular anatomy in ho-
mozygous null ICAM-1 mice (right) and wild-
type controls (left). India ink staining of cere-
brovascular anatomy with an inferior view of 
the circle of Willis demonstrates that there 
were no gross anatomic differences in the vas-
cular pattern of the cerebral circulation, with 
intact posterior communicating arteries in 
both.
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chemic event, cerebral infarcts were smaller, with improved
cerebral perfusion after the ischemic event. These data are
quite similar to those reported in a rabbit model of throm-
boembolic stroke, in which immunodepletion of neutrophils
resulted both in reduced infarction volume and improved
blood flow (35). Because neutrophils contribute to murine
postischemic cerebral injury, we were able to pursue a strategy
to elucidate the role of ICAM-1 in the pathophysiology of
stroke using deletionally mutant ICAM-1 mice (24). Our ex-
periments indicate that homozygous null ICAM-1 mice are
relatively resistant to the deleterious effects of cerebral is-
chemia and reperfusion.
To demonstrate the role of both neutrophils and ICAM-1
in the pathogenesis of tissue injury in stroke, the studies re-
ported here used several methods for assessing stroke out-
come. Although numerous investigators have used TTC stain-
ing to quantify cerebral infarct volumes (26, 30–32, 37, 53),
there has been some controversy as to the accuracy of this
method, especially when evaluated early after the ischemic
event. In the TTC method, TTC reacts with intact oxidative
enzymes on mitochondrial cristae and is thereby reduced to a
colored formazan (54). TTC staining is unreliable before 2 h of
ischemia have elapsed; beyond 36 h, cells infiltrating into the
infarcted tissue can stain positively with TTC, thereby obscur-
ing the clear demarcation between infarcted and noninfarcted
tissues seen with earlier staining (31). Although the size of the
infarct delineated by TTC staining correlates well with infarct
size delineated by hematoxylin and eosin staining (30, 32), di-
rect morphometric measurements tend to overestimate infarct
volumes due to cerebral edema, especially during the first 3 d
after the ischemic event (32). Even given these limitations,
however, the studies reported here incorporate three addi-
tional methods to define the role of neutrophils and ICAM-1
in stroke outcome, including neurologic deficit score, relative
cerebral blood flow to the affected area, and mortality. These
additional measures, which do not depend upon the accuracy
of TTC staining, contribute strongly to our identification of a
pathogenic role for both neutrophils and ICAM-1 in stroke.
There has been a recent profusion of scientific studies ex-
ploring the mechanistic basis for neutrophil recruitment to
postischemic tissues. Endothelial cells appear to be the chief
regulators of neutrophil traffic, regulating the processes of neu-
trophil chemoattraction, adhesion, and emigration from the
vasculature (55). When exposed to a hypoxic environment as a
paradigm for tissue ischemia, endothelial cells synthesize the
potent neutrophil chemoattractant and activator IL-8 (9), the
blockade of which appears to be beneficial in a lung model of
ischemia and reperfusion (6). In addition, hypoxic endothelial
cells synthesize the proinflammatory cytokine IL-1 (8), which
can upregulate endothelial expression of the neutrophil adhe-
sion molecules E-selectin and ICAM-1 in an autocrine fashion
(8, 9, 56). Other neutrophil adhesion mechanisms may also be
activated in the brain after ischemia, such as release of P-selec-
tin from preformed storage pools within Weibel-Palade body
membranes (10). In a primate model, P-selectin expression
was rapidly and persistently enhanced after focal middle cere-
bral artery ischemia and reperfusion (18). Although P-selec-
tin–dependent neutrophil recruitment appears to be delete-
rious after cardiac ischemia and reperfusion (57), its
pathophysiologic relevance in the setting of stroke has not yet
been determined. While hypoxia induces de novo synthesis of
the bioactive lipid PAF (11), in a spinal cord ischemia reperfu-
sion model, PAF antagonism offered no incremental benefit
when given simultaneously with antibody to CD11/CD18 (48).
Understanding the role of ICAM-1 in the pathophysiology
of stroke appears to be of particular relevance in humans for
several reasons. Increased cerebrovascular ICAM-1 expres-
sion has been demonstrated in primates by 4 h of ischemia and
reperfusion, particularly in the lenticulostriate microvascula-
ture (18). An autopsy study of recent cerebral infarcts in hu-
mans also demonstrated increased ICAM-1 expression (20).
Since rats also express cerebral vascular ICAM-1 within 24 h
Figure 7. Role of ICAM-1 in 
stroke outcome. Transient mid-
dle cerebral artery occlusion was 
performed as described in 
ICAM-1 1/1 (Wild Type, n 5 
16) or ICAM-1 2/2 (n 5 13) 
mice, and indices of stroke out-
come were measured as de-
scribed in Fig. 2. (A) Effect of 
ICAM-1 on infarct volume, (B) 
neurologic deficit score, (C) cere-
bral blood flow, and (D) mortal-
ity. *P , 0.05, **P , 0.01.
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in both a photochemically induced model of rat cerebral is-
chemia (19) and a middle cerebral artery occlusion model (12),
these data suggested the potential usefulness of transgenic
ICAM-1–deficient mice in elucidating the pathophysiologic
significance of increased postcerebral ischemic ICAM-1 ex-
pression. In particular, the time frame of ICAM-1 expression
(increased by 4–24 h) in these models suggests that ICAM-1–
mediated neutrophil–endothelial interactions may be targeted
in future pharmacologic strategies to improve human stroke
outcome, as this time frame represents a realistic clinical win-
dow for therapeutic intervention.
Although neutropenic animals demonstrated increased re-
gional cerebral blood flow compared with controls, compared
with neutropenic animals, ICAM-1–deficient mice tended to
have even higher ipsilateral cerebral blood flows at 24 h. This
observation may relate to the no-reflow phenomenon, wherein
blood flow fails to return to preobstruction levels even after re-
lease of a temporary vascular occlusion. A significant body of
previous work has implicated neutrophil plugging of capillary
microvascular beds in this process (58), although in a model of
global cerebral ischemia, an 85% reduction in the circulating
leukocyte count did not decrease the incidence or severity of
reflow failure (49). Our data suggest that non–neutrophil-
dependent mechanisms, which nevertheless involve ICAM-1,
may contribute to cerebrovascular postischemic no-reflow. Since
macrophages and lymphocytes both express LFA-1, which me-
diates an adhesive interaction with endothelial cell ICAM-1
(51), it is possible that ICAM-1–deficient mice have dimin-
ished recruitment of these mononuclear cells, a possibility
which is currently the subject of further investigation in our
laboratory. This hypothesis is supported by multiple patho-
logic observations demonstrating macrophage and lymphocyte
accumulation by 1–3 d after cerebral infarction (12, 17, 19,
34, 59).
Taken together, our studies indicate that, in a murine
model of focal cerebral ischemia and reperfusion, neutrophils
accumulate in the infarcted hemisphere and that neutropenic
animals demonstrate cerebral protection. Increased expression
of ICAM-1 on cerebral endothelial cells appears to be an im-
portant mechanism driving this neutrophil recruitment, and
mice which are unable to express ICAM-1 demonstrate im-
proved postischemic blood flows, reduced infarction volumes,
and reduced mortality. These data suggest that pharmacologic
strategies targeted at interfering with neutrophil–endothelial
interactions may improve the outcome after stroke in humans.
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